{"id":"https://openalex.org/W2063362301","doi":"https://doi.org/10.1177/0883073810379639","title":"Association of Rapidly Progressive Moyamoya Syndrome With Bevacizumab Treatment for Glioblastoma in a Child With Neurofibromatosis Type 1","display_name":"Association of Rapidly Progressive Moyamoya Syndrome With Bevacizumab Treatment for Glioblastoma in a Child With Neurofibromatosis Type 1","publication_year":2010,"publication_date":"2010-09-07","ids":{"openalex":"https://openalex.org/W2063362301","doi":"https://doi.org/10.1177/0883073810379639","mag":"2063362301","pmid":"https://pubmed.ncbi.nlm.nih.gov/20823033"},"language":"en","primary_location":{"id":"doi:10.1177/0883073810379639","doi":"https://doi.org/10.1177/0883073810379639","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0883073810379639","pdf_url":null,"source":{"id":"https://openalex.org/S70982952","display_name":"Journal of Child Neurology","issn_l":"0883-0738","issn":["0883-0738","1702-6075","1708-8283","1708-8828"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082334822","display_name":"Nicole J. Ullrich","orcid":"https://orcid.org/0000-0001-5623-3362","observed_orcids":["https://orcid.org/0000-0001-5623-3362"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicole J. Ullrich","raw_affiliation_strings":["Department of Neurology, Children's Hospital Boston, Boston, Massachusetts, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Children's Hospital Boston, Boston, Massachusetts, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts,","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081689133","display_name":"MaryAnn Zimmerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MaryAnn Zimmerman","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, Department of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, Department of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059629301","display_name":"Edward R. Smith","orcid":"https://orcid.org/0000-0002-6317-8450","observed_orcids":["https://orcid.org/0000-0002-6317-8450"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Smith","raw_affiliation_strings":["Department of Neurosurgery, Children's Hospital Boston, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, Children's Hospital Boston, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000376945","display_name":"Mira Irons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mira Irons","raw_affiliation_strings":["Department of Genetics, Children's Hospital Boston, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genetics, Children's Hospital Boston, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021120123","display_name":"Karen Jean Marcus","orcid":"https://orcid.org/0000-0001-5156-6336","observed_orcids":["https://orcid.org/0000-0001-5156-6336","https://orcid.org/0009-0000-4431-398X"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Marcus","raw_affiliation_strings":["Department of Radiation Oncology, Children's Hospital Boston, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Children's Hospital Boston, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060208068","display_name":"Mark W. Kieran","orcid":"https://orcid.org/0000-0003-2184-7692","observed_orcids":["https://orcid.org/0000-0003-2184-7692"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark W. Kieran","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, Department of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, Department of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5082334822"],"corresponding_institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.8512,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.74490196,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"26","issue":"2","first_page":"228","last_page":"230"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12747","display_name":"Moyamoya disease diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12747","display_name":"Moyamoya disease diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/moyamoya-syndrome","display_name":"moyamoya syndrome","score":0.8650000095367432},{"id":"https://openalex.org/keywords/neurofibromatosis-type-1","display_name":"neurofibromatosis type 1","score":0.9900000095367432},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.7419999837875366},{"id":"https://openalex.org/keywords/internal-carotid-artery-stenosis","display_name":"internal carotid artery stenosis","score":0.8629999756813049},{"id":"https://openalex.org/keywords/pediatric-stroke","display_name":"pediatric stroke","score":0.421999990940094},{"id":"https://openalex.org/keywords/drug-induced-vasculopathy","display_name":"drug-induced vasculopathy","score":0.6740000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8120795488357544},{"id":"https://openalex.org/C2778984943","wikidata":"https://www.wikidata.org/wiki/Q847605","display_name":"Neurofibromatosis","level":2,"score":0.8061386346817017},{"id":"https://openalex.org/C2776548475","wikidata":"https://www.wikidata.org/wiki/Q1951267","display_name":"Moyamoya disease","level":2,"score":0.6480113863945007},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6266049146652222},{"id":"https://openalex.org/C2778679214","wikidata":"https://www.wikidata.org/wiki/Q1935832","display_name":"Neurofibromatosis type 2","level":3,"score":0.5577977895736694},{"id":"https://openalex.org/C2778102573","wikidata":"https://www.wikidata.org/wiki/Q7616509","display_name":"Neurofibromatosis type I","level":3,"score":0.535459041595459},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.4431699514389038},{"id":"https://openalex.org/C2910347904","wikidata":"https://www.wikidata.org/wiki/Q3010352","display_name":"Cerebrovascular disorder","level":2,"score":0.43571770191192627},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34441760182380676},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3401045501232147},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.13154560327529907},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.12082567811012268}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009072","descriptor_name":"Moyamoya Disease","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D009456","descriptor_name":"Neurofibromatosis 1","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009456","descriptor_name":"Neurofibromatosis 1","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/0883073810379639","doi":"https://doi.org/10.1177/0883073810379639","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0883073810379639","pdf_url":null,"source":{"id":"https://openalex.org/S70982952","display_name":"Journal of Child Neurology","issn_l":"0883-0738","issn":["0883-0738","1702-6075","1708-8283","1708-8828"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child Neurology","raw_type":"journal-article"},{"id":"pmid:20823033","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20823033","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child neurology","raw_type":"Case Reports"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.950.8081","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.950.8081","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jcn.sagepub.com/content/26/2/228.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1974408717","https://openalex.org/W1976469530","https://openalex.org/W2004251134","https://openalex.org/W2059840844","https://openalex.org/W2092473822","https://openalex.org/W2098126126","https://openalex.org/W2127745545","https://openalex.org/W2144023881","https://openalex.org/W2168640086","https://openalex.org/W2169334132","https://openalex.org/W2169406351"],"related_works":["https://openalex.org/W7095939884","https://openalex.org/W2078135917","https://openalex.org/W4220931459","https://openalex.org/W2073716145","https://openalex.org/W2793834488","https://openalex.org/W2997552608","https://openalex.org/W3125890284","https://openalex.org/W2110028758","https://openalex.org/W1987693740","https://openalex.org/W4382359081"],"abstract_inverted_index":{"Neurofibromatosis":[0],"type":[1,23,77],"1":[2,24,78],"is":[3,35],"a":[4,36,47,69,72],"common":[5],"multisystemic":[6],"disorder":[7],"that":[8,39],"can":[9],"result":[10,48],"in":[11],"tumors":[12],"of":[13,49,52,60,71],"the":[14,53,90],"central":[15],"and":[16,58],"peripheral":[17],"nervous":[18],"system.":[19],"Individuals":[20],"with":[21,75,79,89],"neurofibromatosis":[22,76],"are":[25],"also":[26],"at":[27],"increased":[28],"risk":[29],"to":[30,43],"develop":[31,44],"moyamoya":[32,85],"syndrome,":[33],"which":[34],"cerebrovascular":[37],"condition":[38],"predisposes":[40],"affected":[41],"individuals":[42],"strokes":[45],"as":[46],"progressive":[50,84],"narrowing":[51],"intracranial":[54],"internal":[55],"carotid":[56],"arteries":[57],"failure":[59],"adequate":[61],"blood":[62],"supply":[63],"through":[64],"collateral":[65],"vessels.":[66],"We":[67],"report":[68],"case":[70],"young":[73],"boy":[74],"glioblastoma":[80],"who":[81],"developed":[82],"rapidly":[83],"vasculopathy":[86],"after":[87],"treatment":[88],"angiogenesis":[91],"inhibitor":[92],"bevacizumab.":[93]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}